Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY14.31 CNY
Change Today +0.02 / 0.14%
Volume 119.2M
600518 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Open
CNY13.65
Previous Close
CNY14.29
Day High
CNY14.58
Day Low
CNY13.65
52 Week High
06/11/15 - CNY25.89
52 Week Low
09/17/14 - CNY7.44
Market Cap
62.9B
Average Volume 10 Days
138.1M
EPS TTM
CNY0.61
Shares Outstanding
4.4B
EX-Date
06/16/15
P/E TM
23.4x
Dividend
CNY0.16
Dividend Yield
1.12%
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices in China. The company's principal products comprise Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. It also offers chemical drugs, such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol, pseudoephedrine hydrochloride tablets, and others. In addition, the company wholesales and retails in other medical materials comprising bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jieyang, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical Co., Ltd. Approves Amendments to Articles of Association

Kangmei Pharmaceutical Co., Ltd. at its Board Meeting held on August 26, 2015, approved the amendments to the Articles of Association of the company.

Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Half of 2015

Kangmei Pharmaceutical Co., Ltd. reported earnings results for the first half of 2015. For the period, the company reported basic earnings per share of CNY 0.326 and weighted average return on net assets of 8.22%.

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Aug 26, 2015

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Aug 26, 2015. Agenda: To consider and approve the semi-annual report of 2015 and its abstract; to consider special report on deposit and actual usage of raised funds in 1st half of 2015; to consider amendment to Articles of Association; and to handle change registration at Industrial and Commercial Administration Authority.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY14.31 CNY +0.02

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies
 

Industry Analysis

600518

Industry Average

Valuation 600518 Industry Range
Price/Earnings 22.7x
Price/Sales 3.5x
Price/Book 3.5x
Price/Cash Flow 22.8x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit www.kangmei.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.